Kazuko Kudo

Toyoake, Japan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 75 publications

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Stepwise malignant transformation from MHL to UESL via activation of C19MC and loss of TP53.

Journal: NPJ precision oncology

Published: February 14, 2026

Hearing loss in Langerhans cell histiocytosis: close association with central nervous system consequences.

Hearing loss in Langerhans cell histiocytosis: close association with central nervous system consequences.

Journal: International journal of hematology

Published: July 28, 2025

Whole-genome sequencing reveals genetic backgrounds in Japanese patients with hemophagocytic lymphohistiocytosis treated with the HLH-2004 protocol.

Whole-genome sequencing reveals genetic backgrounds in Japanese patients with hemophagocytic lymphohistiocytosis treated with the HLH-2004 protocol.

Journal: International journal of hematology

Published: January 22, 2025

Characteristics of long-term complications in Langerhans cell histiocytosis

Characteristics of long-term complications in Langerhans cell histiocytosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: October 02, 2024

Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan.

Phase II study in children and adults under 40 years with newly diagnosed Langerhans cell histiocytosis: protocol for an LCH-19-MSMFB clinical trial in Japan.

Journal: BMJ open

Published: June 23, 2024

Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?

Future Perspective for ALK-Positive Anaplastic Large Cell Lymphoma with Initial Central Nervous System (CNS) Involvement: Could Next-Generation ALK Inhibitors Replace Brain Radiotherapy for the Prevention of Further CNS Relapse?

Journal: Pediatric reports

Published: February 26, 2023

Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.

Intensification of treatment with vinca alkaloid does not improve outcomes in pediatric patients with Langerhans cell histiocytosis: results from the JPLSG LCH-12 study.

Journal: International journal of hematology

Published: September 20, 2022

Systemic herpes simplex virus infection in a child with eczema herpeticum.

Systemic herpes simplex virus infection in a child with eczema herpeticum.

Journal: Pediatric dermatology

Published: June 21, 2022

Elucidated pathogenesis and therapeutic prospects in Langerhans cell histiocytosis

Elucidated pathogenesis and therapeutic prospects in Langerhans cell histiocytosis

Journal: [Rinsho ketsueki] The Japanese journal of clinical hematology

Published: June 06, 2022

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.

BRAF V600E-positive cells as molecular markers of bone marrow disease in pediatric Langerhans cell histiocytosis.

Journal: Haematologica

Published: August 23, 2021

An aggressive systemic mastocytosis preceded by ovarian dysgerminoma.

An aggressive systemic mastocytosis preceded by ovarian dysgerminoma.

Journal: BMC cancer

Published: September 25, 2020

Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan.

Salvage therapy with 2-chlorodeoxyadenosine for refractory and relapsed pediatric Langerhans cell histiocytosis: an updated nationwide survey in Japan.

Journal: International journal of hematology

Published: September 04, 2020

Showing 1-12 of 75

Last Updated: 09/26/2026